Café

© 2026 Longbridge｜Terms of Service Privacy Policy

LNAI

LNAI

2.1552.05%( -0.045 )

LongbridgeAI

Lunai Bioworks shares are trading higher after CEO letter highlights defense contract, neurology pipeline, and litigation against naked short selling.

benzinga_article

Jun 17, 2026 at 11:59 AM

Lunai Bioworks shares are trading higher after CEO letter highlights defense contract, neurology pipeline, and litigation against naked short selling.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Lunai Bioworks

USLNAI

-2.05%

Lunai Bioworks

USRENB